I

Instil Bio Inc
NASDAQ:TIL

Watchlist Manager
Instil Bio Inc
NASDAQ:TIL
Watchlist
Price: 23.64 USD -14.04% Market Closed
Market Cap: 155.1m USD

Relative Value

There is not enough data to reliably calculate the relative value of TIL.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TIL Relative Value
Base Case
Not Available
I
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.3
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-7.4
Industry
23.3
Forward
-1.8
vs History
vs Industry
Median 3Y
-6.8
Median 5Y
-10.5
Industry
19.8
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-8.9
Industry
22.6
vs History
62
vs Industry
65
Median 3Y
2.3
Median 5Y
4.8
Industry
2.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
26
Median 3Y
-6.8
Median 5Y
-8.8
Industry
4.7
Forward
-2.1
vs History
vs Industry
24
Median 3Y
-6.3
Median 5Y
-8.5
Industry
4.8
Forward
-1.6
vs History
vs Industry
28
Median 3Y
-6.2
Median 5Y
-9.6
Industry
5.3
vs History
vs Industry
24
Median 3Y
-5.3
Median 5Y
-6.6
Industry
3.8
vs History
62
vs Industry
62
Median 3Y
2.4
Median 5Y
6.6
Industry
5

Multiples Across Competitors

TIL Competitors Multiples
Instil Bio Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Instil Bio Inc
NASDAQ:TIL
155.1m USD 0 -2 -2.8 -2.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 770 229.5 -160 504.9 -194 904.1 -192 680.1
US
Abbvie Inc
NYSE:ABBV
330.2B USD 5.8 79.5 15.2 22.4
US
Amgen Inc
NASDAQ:AMGN
157.1B USD 4.6 26.5 14.3 23.5
US
Gilead Sciences Inc
NASDAQ:GILD
138.4B USD 4.8 23.2 10.1 13.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.4B USD 10.6 -118.7 25.2 26.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.1 -532.3 -579.6 -564.2
AU
CSL Ltd
ASX:CSL
120.1B AUD 5.1 28.4 17.5 21.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
57.7B USD 4.1 12.8 11.4 12.8
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.6 -66.4 -59.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.9B USD 17.8 -155.3 -696.8 -349.2
P/S Multiple
Revenue Growth P/S to Growth
US
I
Instil Bio Inc
NASDAQ:TIL
Average P/S: 3 377 238.9
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 770 229.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.6
10%
1.1
US
E
Epizyme Inc
F:EPE
2 086.1
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.1
4%
1
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.8
29%
0.6
P/E Multiple
Earnings Growth PEG
US
I
Instil Bio Inc
NASDAQ:TIL
Average P/E: 34.1
Negative Multiple: -2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 504.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.5
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.2
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118.7 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.3 N/A N/A
AU
CSL Ltd
ASX:CSL
28.4
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.8
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -155.3 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
I
Instil Bio Inc
NASDAQ:TIL
Average EV/EBITDA: 15.6
Negative Multiple: -2.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 904.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.3
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.6 N/A N/A
AU
CSL Ltd
ASX:CSL
17.5
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.4
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.4 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -696.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
I
Instil Bio Inc
NASDAQ:TIL
Average EV/EBIT: 20.2
Negative Multiple: -2.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 680.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.5
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.9
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.2 N/A N/A
AU
CSL Ltd
ASX:CSL
21.9
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.8
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -349.2 N/A N/A